Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Ulipristal acetate
Drug ID BADD_D02313
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D09687
MeSH ID C555622
PubChem ID 130904
TTD Drug ID Not Available
NDC Product Code 53183-4037; 50090-5422; 67296-1466; 73302-456; 53002-2630
UNII YF7V70N02B
Synonyms ulipristal acetate | (11beta)-17-(acetyloxy)-11-(4-(dimethylamino)phenyl)-19-norpregna-4,9-diene-3,20-dione | Ella norpregnadiene | Esmya
Chemical Information
Molecular Formula C30H37NO4
CAS Registry Number 126784-99-4
SMILES CC(=O)C1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001---
Abdominal pain07.01.05.002--
Acne23.02.01.001---
Dizziness02.11.04.006; 17.02.05.003; 24.06.02.007--
Dysmenorrhoea21.01.01.002--
Fatigue08.01.01.002--
Headache17.14.01.001--
Nausea07.01.07.001--
The 1th Page    1    Total 1 Pages